239 related articles for article (PubMed ID: 31164858)
1. Diagnostic Yield and Treatment Impact of Targeted Exome Sequencing in Early-Onset Epilepsy.
Demos M; Guella I; DeGuzman C; McKenzie MB; Buerki SE; Evans DM; Toyota EB; Boelman C; Huh LL; Datta A; Michoulas A; Selby K; Bjornson BH; Horvath G; Lopez-Rangel E; van Karnebeek CDM; Salvarinova R; Slade E; Eydoux P; Adam S; Van Allen MI; Nelson TN; Bolbocean C; Connolly MB; Farrer MJ
Front Neurol; 2019; 10():434. PubMed ID: 31164858
[TBL] [Abstract][Full Text] [Related]
2. A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy.
Howell KB; Eggers S; Dalziel K; Riseley J; Mandelstam S; Myers CT; McMahon JM; Schneider A; Carvill GL; Mefford HC; ; Scheffer IE; Harvey AS
Epilepsia; 2018 Jun; 59(6):1177-1187. PubMed ID: 29750358
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.
Tan TY; Dillon OJ; Stark Z; Schofield D; Alam K; Shrestha R; Chong B; Phelan D; Brett GR; Creed E; Jarmolowicz A; Yap P; Walsh M; Downie L; Amor DJ; Savarirayan R; McGillivray G; Yeung A; Peters H; Robertson SJ; Robinson AJ; Macciocca I; Sadedin S; Bell K; Oshlack A; Georgeson P; Thorne N; Gaff C; White SM
JAMA Pediatr; 2017 Sep; 171(9):855-862. PubMed ID: 28759686
[TBL] [Abstract][Full Text] [Related]
4. The Utility of Whole Exome Sequencing in Diagnosing Pediatric Neurological Disorders.
Muthaffar OY
Balkan J Med Genet; 2020 Nov; 23(2):17-24. PubMed ID: 33816068
[TBL] [Abstract][Full Text] [Related]
5. Reducing the Cost of the Diagnostic Odyssey in Early Onset Epileptic Encephalopathies.
Joshi C; Kolbe DL; Mansilla MA; Mason SO; Smith RJ; Campbell CA
Biomed Res Int; 2016; 2016():6421039. PubMed ID: 27243033
[TBL] [Abstract][Full Text] [Related]
6. Clinical Impact and Cost-Effectiveness of Whole Exome Sequencing as a Diagnostic Tool: A Pediatric Center's Experience.
Valencia CA; Husami A; Holle J; Johnson JA; Qian Y; Mathur A; Wei C; Indugula SR; Zou F; Meng H; Wang L; Li X; Fisher R; Tan T; Hogart Begtrup A; Collins K; Wusik KA; Neilson D; Burrow T; Schorry E; Hopkin R; Keddache M; Harley JB; Kaufman KM; Zhang K
Front Pediatr; 2015; 3():67. PubMed ID: 26284228
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children.
Aaltio J; Hyttinen V; Kortelainen M; Frederix GWJ; Lönnqvist T; Suomalainen A; Isohanni P
Eur J Paediatr Neurol; 2022 Jan; 36():30-36. PubMed ID: 34852981
[TBL] [Abstract][Full Text] [Related]
8. From diagnosis to treatment in genetic epilepsies: Implementation of precision medicine in real-world clinical practice.
De Wachter M; Schoonjans AS; Weckhuysen S; Van Schil K; Löfgren A; Meuwissen M; Jansen A; Ceulemans B
Eur J Paediatr Neurol; 2024 Jan; 48():46-60. PubMed ID: 38039826
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and cost utility of whole exome sequencing in peripheral neuropathy.
Walsh M; Bell KM; Chong B; Creed E; Brett GR; Pope K; Thorne NP; Sadedin S; Georgeson P; Phelan DG; Day T; Taylor JA; Sexton A; Lockhart PJ; Kiers L; Fahey M; Macciocca I; Gaff CL; Oshlack A; Yiu EM; James PA; Stark Z; Ryan MM;
Ann Clin Transl Neurol; 2017 May; 4(5):318-325. PubMed ID: 28491899
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability.
Monroe GR; Frederix GW; Savelberg SM; de Vries TI; Duran KJ; van der Smagt JJ; Terhal PA; van Hasselt PM; Kroes HY; Verhoeven-Duif NM; Nijman IJ; Carbo EC; van Gassen KL; Knoers NV; Hövels AM; van Haelst MM; Visser G; van Haaften G
Genet Med; 2016 Sep; 18(9):949-56. PubMed ID: 26845106
[TBL] [Abstract][Full Text] [Related]
11. Identification of genetic causes in children with unexplained epilepsy based on trio-whole exome sequencing.
Chengyan L; Chupeng X; You W; Yinhui C; Binglong H; Dang A; Ling L; Chuan T
Clin Genet; 2024 Mar; ():. PubMed ID: 38468460
[TBL] [Abstract][Full Text] [Related]
12. Use of Whole-Exome Sequencing for Diagnosis of Limb-Girdle Muscular Dystrophy: Outcomes and Lessons Learned.
Ghaoui R; Cooper ST; Lek M; Jones K; Corbett A; Reddel SW; Needham M; Liang C; Waddell LB; Nicholson G; O'Grady G; Kaur S; Ong R; Davis M; Sue CM; Laing NG; North KN; MacArthur DG; Clarke NF
JAMA Neurol; 2015 Dec; 72(12):1424-32. PubMed ID: 26436962
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic yield of genetic tests in epilepsy: A meta-analysis and cost-effectiveness study.
Sánchez Fernández I; Loddenkemper T; Gaínza-Lein M; Sheidley BR; Poduri A
Neurology; 2019 Jan; 92(5):e418-e428. PubMed ID: 30610098
[TBL] [Abstract][Full Text] [Related]
14. Exome sequencing identifies molecular diagnosis in children with drug-resistant epilepsy.
Tsang MH; Leung GK; Ho AC; Yeung KS; Mak CC; Pei SL; Yu MH; Kan AS; Chan KY; Kwong KL; Lee SL; Yung AW; Fung CW; Chung BH
Epilepsia Open; 2019 Mar; 4(1):63-72. PubMed ID: 30868116
[TBL] [Abstract][Full Text] [Related]
15. Exome sequencing for paediatric-onset diseases: impact of the extensive involvement of medical geneticists in the diagnostic odyssey.
Mak CC; Leung GK; Mok GT; Yeung KS; Yang W; Fung CW; Chan SH; Lee SL; Lee NC; Pfundt R; Lau YL; Chung BH
NPJ Genom Med; 2018; 3():19. PubMed ID: 30109123
[TBL] [Abstract][Full Text] [Related]
16. Positioning whole exome sequencing in the diagnostic pathway for rare disease to optimise utility: a protocol for an observational cohort study and an economic evaluation.
Hayeems RZ; Bernier F; Boycott KM; Hartley T; Michaels-Igbokwe C; Marshall DA
BMJ Open; 2022 Oct; 12(10):e061468. PubMed ID: 36216418
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Challenges of Neuromuscular Disorders after Whole Exome Sequencing.
Chen PS; Chao CC; Tsai LK; Huang HY; Chien YH; Huang PH; Hwu WL; Hsieh ST; Lee NC; Hsueh HW; Yang CC
J Neuromuscul Dis; 2023; 10(4):667-684. PubMed ID: 37066920
[TBL] [Abstract][Full Text] [Related]
18. Clinical application of prospective whole-exome sequencing in the diagnosis of genetic disease: Experience of a regional disease center in South Korea.
Lee JY; Oh SH; Keum C; Lee BL; Chung WY
Ann Hum Genet; 2024 Mar; 88(2):101-112. PubMed ID: 37795942
[TBL] [Abstract][Full Text] [Related]
19. Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.
Ewans LJ; Minoche AE; Schofield D; Shrestha R; Puttick C; Zhu Y; Drew A; Gayevskiy V; Elakis G; Walsh C; Adès LC; Colley A; Ellaway C; Evans CA; Freckmann ML; Goodwin L; Hackett A; Kamien B; Kirk EP; Lipke M; Mowat D; Palmer E; Rajagopalan S; Ronan A; Sachdev R; Stevenson W; Turner A; Wilson M; Worgan L; Morel-Kopp MC; Field M; Buckley MF; Cowley MJ; Dinger ME; Roscioli T
Eur J Hum Genet; 2022 Oct; 30(10):1121-1131. PubMed ID: 35970915
[TBL] [Abstract][Full Text] [Related]
20. Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.
Sawyer SL; Hartley T; Dyment DA; Beaulieu CL; Schwartzentruber J; Smith A; Bedford HM; Bernard G; Bernier FP; Brais B; Bulman DE; Warman Chardon J; Chitayat D; Deladoëy J; Fernandez BA; Frosk P; Geraghty MT; Gerull B; Gibson W; Gow RM; Graham GE; Green JS; Heon E; Horvath G; Innes AM; Jabado N; Kim RH; Koenekoop RK; Khan A; Lehmann OJ; Mendoza-Londono R; Michaud JL; Nikkel SM; Penney LS; Polychronakos C; Richer J; Rouleau GA; Samuels ME; Siu VM; Suchowersky O; Tarnopolsky MA; Yoon G; Zahir FR; ; ; Majewski J; Boycott KM
Clin Genet; 2016 Mar; 89(3):275-84. PubMed ID: 26283276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
